Je Shield Sd Vaccine Pfs 0.5ml Injection

The Je Shield Sd Vaccine Pfs 0.5ml Injection is an inactivated vaccine designed for the prevention of Japanese encephalitis (JE). It contains inactivated Japanese Encephalitis virus protein 5mcg, which works by stimulating the body's immune system to produce antibodies against the virus. This vaccine is crucial for safeguarding individuals against Japanese encephalitis, a serious viral infection transmitted by infected mosquitoes that can lead to severe neurological complications.

This vaccine is indicated for use in universal immunization programs in selected areas endemic to Japanese encephalitis. It is also recommended for individuals traveling to JE-endemic regions, particularly for stays exceeding one month, frequent travelers to such areas, and shorter-term travelers with an increased risk of exposure. The primary vaccination is typically administered as a single dose via subcutaneous injection. It is suitable for children aged 1 to 3 years and adults aged 18 to 49 years.

Key Features : 

Antigen Composition: Contains inactivated Japanese Encephalitis virus protein 5mcg, providing active immunization against the Japanese Encephalitis virus.
Approved Indications: Prevents Japanese encephalitis in endemic areas and for travelers to high-risk regions.
Target Population: Recommended for children aged 1 to 3 years and adults aged 18 to 49 years.
Cold-chain Storage: Requires storage in a refrigerator at 2-8°C; must not be frozen.
Route of Administration: Administered as a subcutaneous injection.
Dosing Schedule: Provided as a single dose vaccine.
Regulatory Information: Marketed by Abbott and developed in collaboration with the National Institute of Virology, India.